Remus Pharmaceuticals IPO Subscription Status Live

Remus Pharmaceuticals IPO subscribed 57.21 times. The public issue subscribed 49.81 times in the retail category, 10.75 times in QIB, and 229.31 times in the NII category by May 19, 2023.

Investor CategorySubscription (times)Shares Bid forTotal Amount (Rs Cr.)*
Qualified Institutions10.7514,92,000183.37
Non-Institutional Buyers229.3195,45,0001,173.08
Retail Investors49.8148,37,600594.54
Total 57.211,58,74,6001,950.99

Total Application : 48,376 (49.77 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.

Remus Pharmaceuticals IPO (Day-wise) Subscription Details (times)

Day 1
May 17, 2023
Day 2
May 18, 2023
Day 3
May 19, 2023

Remus Pharmaceuticals IPO Shares Offered

Remus Pharmaceuticals IPO is a public issue of 277,500 equity shares. The issue offers 97,125 shares to retail investors, 138,750 shares to qualified institutional buyers, and 41,625 shares to non-institutional investors.

CategoryShares OfferedAmount (Rs Cr) Size (%)

* Market maker portion is not included.

IPO Investor Categories

  • Qualified Institutional Buyers (QIB)

    Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.

  • Non-Institutional Investors(NII)

    Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.

    NII category has two subcategories:

    1. sNII (bids below Rs 10L)

      The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).

    2. bNII (bids above Rs 10L)

      The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).

  • Retail Individual Investors(RII)

    The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.

  • Employee (EMP)

    A category of eligible employees who have a reserved quota in the IPO.

  • Others

    A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The subscription data is taken from the NSE and BSE websites. They are subject to change on a real-time basis. The subscription data provided are for information purposes only and provided by Chittorgarh.com on an 'AS IS' and 'AS AVAILABLE' basis and without warranty, express or implied. Our website does not guarantee or warrant the accuracy, adequacy, or completeness of the information received through the said websites. Chittorgarh.com holds no responsibility of any kind as regards any discrepancies, errors, omissions, losses, or damages. Chittorgarh.com including its affiliates and any of its directors, and employees, shall not be liable for any loss, or damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of data received. The recipient alone shall be fully responsible / are liable for any decision taken based on such information/data. All recipients should before acting upon the said information make their investigation, and seek appropriate professional advice.

Remus Pharmaceuticals IPO Subscription FAQs

The Remus Pharmaceuticals IPO is subscribed 57.21 by May 19, 2023.

Remus Pharmaceuticals IPO Subscription

Investor CategorySubscription (times)
Qualified Institutional10.75
Non Institutional229.31
Retail Individual49.81
Employee Reservations[.]
Total Subscription57.21

Retail category of Remus Pharmaceuticals IPO subscribed 49.81 times as of date May 19, 2023. The public issue closes on May 19, 2023 for bidding.

An investor can apply in Remus Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Remus Pharmaceuticals IPO shares are offered online only.

The Remus Pharmaceuticals IPO is subscribed 57.21 by May 19, 2023.

The Remus Pharmaceuticals IPO allotment status is expected on or around May 24, 2023. Visit Remus Pharmaceuticals IPO allotment status to check.

The Remus Pharmaceuticals IPO listing date is Monday, May 29, 2023. The equity share of Remus Pharmaceuticals Limited will list on NSE SME.

Visit Remus Pharmaceuticals IPO subscription status page for real-time bidding information about Remus Pharmaceuticals IPO.

Remus Pharmaceuticals IPO Timetable

IPO Opens OnMay 17, 2023
IPO Closes OnMay 19, 2023
Finalisation of Basis of AllotmentMay 24, 2023
Initiation of RefundsMay 25, 2023
Credit of Shares to Demat AccountMay 26, 2023
IPO Listing DateMay 29, 2023